PART II AND III 2 tm237310d1_partiii.htm PART II AND III

  

Explanatory Note

 

Fisher Wallace Laboratories, Inc. has prepared this Form 1-A/A solely for the purpose of updating Exhibit 4.

 

Part III

 

EXHIBITS

 

1 Posting Agreement with StartEngine Crowdfunding (1)
   
2.1 Amended and Restated Certificate of Incorporation (2)
   
2.2 Certificate of Amendment to Amended and Restated Certificate of Incorporation (3)
   
2.3 Second Certificate of Amendment to Amended and Restated Certificate of Incorporation (4)
   
2.4 Third Certificate of Amendment to Amended and Restated Certificate of Incorporation (5)
   
2.5 Amended and Restated Bylaws (6)
   
4 Form of Subscription Agreement (7)
   
8 Escrow Services Agreement (8)
   
11 Consent of IndigoSpire CPAs & Advisors (9)
   
12  Opinion of Alliance Legal Partners, Inc. (10)

 

(1)Filed as an exhibit to Fisher Wallace Laboratories, Inc. Regulation A Offering Statement on Form 1-A/A filed February 17, 2023 (Commission File No. 024-11229) and incorporated herein by reference. Available at, https://www.sec.gov/Archives/edgar/data/1787792/000110465923023081/tm233488d5_ex1.htm
(2)Filed as an exhibit to Fisher Wallace Laboratories, Inc. Regulation A Offering Statement on Form 1-A/A filed February 17, 2023 (Commission File No. 024-11229) and incorporated herein by reference. Available at, https://www.sec.gov/Archives/edgar/data/1787792/000110465923023081/tm233488d5_ex2-1.htm
(3)Filed as an exhibit to Fisher Wallace Laboratories, Inc. Regulation A Offering Statement on Form 1-A/A filed February 17, 2023 (Commission File No. 024-11229) and incorporated herein by reference. Available at, https://www.sec.gov/Archives/edgar/data/1787792/000110465923023081/tm233488d5_ex2-2.htm
(4)Filed as an exhibit to Fisher Wallace Laboratories, Inc. Regulation A Offering Statement on Form 1-A/A filed February 17, 2023(Commission File No. 024-11229) and incorporated herein by reference. Available at, https://www.sec.gov/Archives/edgar/data/1787792/000110465923023081/tm233488d5_ex2-3.htm
(5)Filed as an exhibit to Fisher Wallace Laboratories, Inc. Regulation A Offering Statement on Form 1-A/A filed February 17, 2023(Commission File No. 024-11229) and incorporated herein by reference. Available at, https://www.sec.gov/Archives/edgar/data/1787792/000110465923023081/tm233488d5_ex2-4.htm
(6)Filed as an exhibit to Fisher Wallace Laboratories, Inc. Regulation A Offering Statement on Form 1-A/A filed February 17, 2023(Commission File No. 024-11229) and incorporated herein by reference. Available at, https://www.sec.gov/Archives/edgar/data/1787792/000110465923023081/tm233488d5_ex2-5.htm
(7)Filed herewith.
(8)Filed as an exhibit to Fisher Wallace Laboratories, Inc. Regulation A Offering Statement on Form 1-A/A filed February 17, 2023(Commission File No. 024-11229) and incorporated herein by reference. Available at, https://www.sec.gov/Archives/edgar/data/1787792/000110465923023081/tm233488d5_ex8.htm
(9)Filed as an exhibit to Fisher Wallace Laboratories, Inc. Regulation A Offering Statement on Form 1-A/A filed February 17, 2023 (Commission File No. 024-11229) and incorporated herein by reference. Available at, https://www.sec.gov/Archives/edgar/data/1787792/000110465923023081/tm233488d5_ex11.htm
(10)Filed as an exhibit to Fisher Wallace Laboratories, Inc. Regulation A Offering Statement on Form 1-A/A filed February 17, 2023(Commission File No. 024-11229) and incorporated herein by reference. Available at, https://www.sec.gov/Archives/edgar/data/1787792/000110465923023081/tm233488d5_ex12.htm

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of Regulation A, the issuer certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form 1-A and has duly caused this Offering Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of New York, State of New York, on February 17, 2023.

 

FISHER WALLACE LABORATORIES, INC.  
   
     
By: /s/ Kelly Roman          Date: February 17, 2023
  Kelly Roman, Chief Executive Officer,
Principal Executive Officer and Director		  
     
     
By: /s/ Charles A. Fisher          Date: February 17, 2023
  Charles A. Fisher, Chief Financial Officer,
Principal Financial Officer, Principal Accounting Officer and Director		  
     
     
By: /s/ Simon Webster          Date: February 17, 2023
  Director